Emerging Technologies are Showing Promise in Early Cancer Detection
Multi-cancer detection tests could be the key to finding certain cancers earlier, screening for multiple cancers at one time and boosting overall survival rates.
The National Cancer Institute has established a third Cancer Screening Research Network that will leverage emerging technologies and develop clinical trials that could lead to earlier detection of different types of cancer. Multi-cancer detection tests are showing a great deal of promise when it comes to screening for certain cancers that could result in a more timely diagnosis and treatment which in turn reduces the number of cancer deaths. Dr. Lori Minasian, deputy director for the Division of Cancer Prevention at NCI, discusses how these tests fit into President Biden’s Cancer Moonshot initiative, what the challenges around the tests are and more details about a new pilot study coming up in 2024.
-
Dr. Lori Minasian Deputy Director for the Division of Cancer Prevention NCI
-
Quantum, Workforce Issues Lead FDA’s Digital Transformation
The FDA is taking a proactive approach to its digital transformation efforts that its tech leaders highlighted in a new IT strategy.
14m listen -
Storytelling Miniseries: The Skill that Can Unite Cross-Generational Teams
The third episode in this Storytelling Miniseries for federal leaders discusses bridging gaps across generations in the workplace.
20m listen -
HHS to Launch 2 Acquisition Programs in FY 2025
The two programs will streamline knowledge and foster two-way communication between industry and the agency.
2m read -
AI Startups Help Detect, Prevent Common Cancers in Women
Brittany Connors, SBIR director of investor relations at NCI, discussed how she is working with startups to develop the technology that better detects breast cancer and cervical cancer in their early stages.
23m listen
